{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T07:21:23Z","timestamp":1648884083834},"reference-count":43,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.4103\/0256-4947.65267","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T08:49:21Z","timestamp":1278578961000},"page":"313-316","source":"Crossref","is-referenced-by-count":2,"title":["An imported enteric fever caused by a quinolone-resistant<i>Salmonella typhi<\/i>"],"prefix":"10.5144","volume":"30","author":[{"given":"Ali M.","family":"Somily","sequence":"first","affiliation":[{"name":"From the Department of Pathology-Microbiology, King Saud College of Medicine, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"key":"e_1_3_2_2_2","volume-title":"The world health report 1996: fighting disease, fostering development","year":"1996"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry CM","year":"2002","journal-title":"N Engl J Med"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1128\/JCM.36.6.1683-1687.1998","article-title":"Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic","volume":"36","author":"Wain J","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/JCM.39.4.1571-1576.2001","article-title":"Quantitation of bacteria in bone marrow from patient with typhoid fever: relation ship between counts and clinical feature","volume":"39","author":"Wain J","year":"2001","journal-title":"J Clin Microbiol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00019048-199409000-00004","article-title":"Quinolones in typhoid fever. Infect","volume":"3","author":"Gotuzzo E","year":"1994","journal-title":"Dis Clin pract"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00001432-199610000-00003","article-title":"The treatment of typhoid fever","volume":"9","author":"White NJ","year":"1996","journal-title":"Current Opin in Infect Dis"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006454-199903000-00007","article-title":"A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children","volume":"18","author":"Cao XT","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.43.6.1441","article-title":"Azihromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that includes patients with multi-drug resistance","volume":"43","author":"Girgis NI","year":"1993","journal-title":"Antimicrob Agents chemother"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","article-title":"A randamrzed controlled comparision of azithromycin and ofloxacin for treatment of multi-drug resistant and ralidixic acid resistant enteric fever","volume":"44","author":"Chinh NT","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4269\/ajtmh.1993.48.108","article-title":"Emergence of multidrug- resistant Salmonella typhi in rural shouthern India","volume":"48","author":"Rao PS","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/516128","article-title":"Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment","volume":"25","author":"Wain J","year":"1997","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_13_2","first-page":"1065","article-title":"Multiple-drug-resistant Salmonella typhi","volume":"336","author":"Mourad AS","year":"1990","journal-title":"Lancet"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3201\/eid0703.017315","article-title":"Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom","volume":"7","author":"Therfall EJ","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3201\/eid0804.010202","article-title":"Salmonella enterica serotype Typhimurium DT 104 isolated from Humans, United State, 1985, 1990 and 1995","volume":"8","author":"Ribot EM","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.279.5353.996","article-title":"Medical consequence of antibiotics use in agriculture","volume":"279","author":"Witte W","year":"1998","journal-title":"Science"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199805073381901","article-title":"Emergence of multidrug- resistant Salmonella enterica serotype typhimurium DT 104 infections in United states","volume":"338","author":"Glynn MK","year":"1998","journal-title":"N Engl J Med"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S0950268800056892","article-title":"A comparision of multiple drug resistance in salmonellas from humans and food animals in England and wale, 1981 and 1990","volume":"111","author":"Threlfall GJ","year":"1993","journal-title":"Epidemiol Infect"},{"key":"e_1_3_2_19_2","first-page":"M100","volume-title":"Performance of standard for antimicrobial susceptibility testing: sixteen informational supplement. CLSI document (M7)","year":"2008"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/323019","article-title":"Salmonella typhi in the past decade : learning to line with resistance","volume":"34","author":"Rodrignes C","year":"2002","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(05)78338-0","article-title":"Epidicic ciprofloxacin- resistant salmonella typhi in Tajidistan","volume":"351","author":"Murdoch DA","year":"1998","journal-title":"Lancet"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3201\/eid0402.980223","article-title":"Molecular fingerprinting of multidrug resistant salmonella enterica serotype typhi","volume":"4","author":"Hampton MD","year":"1998","journal-title":"Emerg infect Dis"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.283.20.2668","article-title":"Laboratory-based surveillance of salmonella serotype Typhi infection in the United States: antimicrobial resistance on the rise","volume":"283","author":"Ackers M-L","year":"2000","journal-title":"JAMA"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/AAC.33.3.283","article-title":"Mechanisms of quinolone resistance in Escherichia coli: characterization of nfx B and cfx B: two mutant resistance loci decreasing norflaxacin accumulation","volume":"33","author":"Hooper DC","year":"1989","journal-title":"Antimicob Agents Chemother"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1574-6968.1992.tb05462.x","article-title":"Cloning and mucleotide sequence of the pseudonona aeruginosa nfxB gene, conferring resistance to new quinolones","volume":"76","author":"Okazki T","year":"1992","journal-title":"FEMS microbial lett"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1073\/pnas.082092899","article-title":"Mechanisms of plasmid-mediated quinolone resistance","volume":"99","author":"Tran Jacoby GA","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_2_27_2","volume-title":"Emerging fluroquinolone resistance 1996-2000. an abstract presented at the International conference on Emerging Infectious Diseases; March 24-27","author":"Rossiter S","year":"2002"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JCM.37.11.3572-3577.1999","article-title":"Detection of decrease fluroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test","volume":"37","author":"Hakanen A","year":"1997","journal-title":"J Clin Microbiol"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic pharmaoodynamic parameters: rationale for antibacterial doing of mice and men","volume":"26","author":"Graig WA","year":"1998","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_30_2","first-page":"281","article-title":"Dose mater? Clin linfect Dis","volume":"159","author":"Craig WA","year":"1989","journal-title":"- Comparatine antibiotic dose effect relations at several doing intervals in murine pneumonitis and thigh- infection models. J infect Dis"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intaveous ciprofloxacin in seriously ill patients","volume":"37","author":"Forrest A","year":"1993","journal-title":"Antimicrob Agents chemother"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/AAC.31.7.1054","article-title":"Comparatine study with exoxacin and netilmicin in a pharmacodymamic model to determine importance of ratio of antibiotic peak concentration to MIC for bacteriocidel activity and emergence of resistante","volume":"31","author":"Blaser J","year":"1987","journal-title":"Antimicrob Agents chemother"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0002-9343(91)90181-V","article-title":"Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics","volume":"91","author":"Paladini JA","year":"1991","journal-title":"Am J Med"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/CMR.2.4.378","article-title":"Fluoroquinolone antimicrobial agents","volume":"2","author":"Wolfson JS","year":"1989","journal-title":"Clin Microbio Rev"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3201\/eid0303.970316","article-title":"Emerging quinolone-resistant Salmonella in the United States","volume":"3","author":"Herikstad H","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/26.2.296","article-title":"The emergence of ciprofloxacin resistance in Salmonella typhimurium","volume":"26","author":"Howard AJ","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/0140-6736(90)91484-R","article-title":"Quinolone resistance in Salmonella: clinical experience","volume":"335","author":"Piddock LJ","year":"1990","journal-title":"Lancet"},{"key":"e_1_3_2_38_2","first-page":"189","article-title":"Decreasing clinical response of quinolones in the treatment of enteric fever","volume":"55","author":"John M","year":"2001","journal-title":"Indian J Med Sci"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1574-6976.2002.tb00596.x","article-title":"Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals","volume":"26","author":"Piddock LJ","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0924-8579(96)00336-6","article-title":"Antimicrobial susceptibility and serogroups of salmonella isolated from RIYADH Saudi Arabia","volume":"4","author":"Kambal AM","year":"1996","journal-title":"Int J Antimirob"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5144\/0256-4947.2004.270","article-title":"Emerging nalidixic acid and ciprofloxacin resistant in non-typhoidal Salmonella isolated from patients having acute diarrheal disease","volume":"4","author":"Pandhotra BR","year":"2004","journal-title":".Ann Saudi Med"},{"key":"e_1_3_2_42_2","first-page":"129","article-title":"Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis","volume":"1","author":"Al-Khuwaiter TS","year":"2008","journal-title":"Saudi Med J"},{"key":"e_1_3_2_43_2","first-page":"210","article-title":"Ceftriaxone therapy in cipro. oxacin treatment failure typhoid fever in children","volume":"113","author":"Dutta P","year":"2001","journal-title":"Indian J Med Res"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1128\/AAC.37.5.1197","article-title":"Ciprofoxacin for treatment of severe typhoid fever in children","volume":"37","author":"Dutta P","year":"1993","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T19:06:32Z","timestamp":1591470392000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.4103\/0256-4947.65267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.4103\/0256-4947.65267"],"URL":"https:\/\/doi.org\/10.4103\/0256-4947.65267","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}